logo
Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday

Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday

Yahoo06-05-2025
We recently published a list of Why These 10 Firms Soared on Monday. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against other Monday's best performers.
The stock market kicked off the trading week on a negative note as investors sold off on a new round of uncertainties from President Donald Trump's tariff policies.
The Nasdaq fell by 0.74 percent, while the S&P 500 dropped 0.64 percent and the Dow Jones was down by 0.24 percent.
Over the weekend, Trump told reporters that the US was negotiating with many countries, 'but at the end of this, I'll set my own deals — because I set the deal, they don't set the deal.'
He added that he had no intentions to talk with Chinese President Xi Jinping, dampening hopes of a potential negotiation between the two of the world's largest economies.
Beyond the major indices, 10 companies stood out with strong gains amid a flurry of fresh developments. In this article, we name Monday's 10 best performers and detail the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.
Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday
A scientist in a lab coat observing a line of medicine pills in a container.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
BioCryst Pharmaceuticals jumped by 23.52 percent on Monday, a second straight day, ending the day at $11.03 apiece following its impressive earnings performance in the first quarter, coupled with a highly optimistic outlook for the rest of the year.
In a statement, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said it swung to a net income of $32,000 from a net loss of $35.38 million in the same period a year earlier as revenues jumped by 57 percent to $145.5 million from $92.76 million year-on-year, thanks to the strong performance of its hereditary angioedema treatment, Orladeyo.
Looking ahead, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said it now expects to be fully profitable for the rest of the year ahead of its original target.
Revenues from Orladeyo alone were expected to settle between $580 million and $600 million, higher than the $535 million to $550 million targeted previously.
Full-year operating expenses were also targeted to settle only between $440 million and $450 million, from the previous $425 million to $435 million.
Overall, BCRX ranks 2nd on our list of Monday's best performers. While we acknowledge the potential of BCRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BCRX but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How the Trump administration could attack state laws it says stifle US economy
How the Trump administration could attack state laws it says stifle US economy

Yahoo

time2 minutes ago

  • Yahoo

How the Trump administration could attack state laws it says stifle US economy

The Trump administration is hunting for state laws that drag down the US economy. But axing statutes it sees as problematic will depend on how it wields the Constitution's powerful Commerce Clause. Last Friday, the Justice Department and the National Economic Council announced a joint initiative to "address" state statutes that "significantly and adversely affect the national economy.' State regulations, policies, causes of action, and practices were also included as targets. The plan is meant to support the White House's deregulation agenda, which President Trump described in a series of separate executive orders issued in January, February, and April. Those orders emphasize the administration's goal of alleviating policies that it views as "unnecessary burdens" on Americans, small businesses, private enterprise, and entrepreneurship. In an unusual twist, the agencies also solicited help from US citizens, asking members of the public to point out economy-slowing state laws and to propose legal theories that could reverse the laws' adverse effects. "They're crowdsourcing their legal theories," said Emily Berman, a constitutional scholar with the University of Houston Law Center. However, the plan stopped short of explaining what theories the administration would rely on to undo suspected harmful state laws. Jeremy Rovinsky, a federal prosecutor who teaches constitutional law at Crestpoint University, said the language used in the DOJ's plan to attack state laws shows that the Trump administration has the Commerce Clause in mind. "It's clear that Trump's lawyers are thinking through it this way," Rovinsky said. "The Supreme Court has allowed the federal government to regulate state power in an almost unlimited way." But the Commerce Clause doesn't guarantee the administration power to alter state law. The provision vests power to regulate commerce in Congress, not in the executive branch. A more straightforward type of challenge, the lawyer said, is one where state law directly conflicts with federal statutes. In those cases, the Justice Department could raise preemption challenges under the Constitution's Supremacy Clause. Preemption challenges argue that a state rule essentially steps on the federal government's toes, Berman said. The Commerce Clause Absent such a clear-cut conflict, the administration would need more legal leverage to countermand state law. That leverage could come from the Commerce Clause, the constitutional scholar said, which empowers Congress to regulate interstate and foreign commerce. "Anything that regulates commerce falls within the scope of Congress's authority, which has been interpreted relatively broadly," Berman said. To tap into the federal government's authority over commerce, the administration would need to persuade lawmakers to pass new federal legislation invalidating state law. Ravinsky said he sees the DOJ's announcement as an opening salvo to persuade members of Congress. "I think the people that are in [Trump's] inner legal circle wrote that document the way they did, because they want to give Congress a heads up to have them codify what he's doing with executive actions into actual congressional legislation," Ravinsky said. Jonathan Entin, professor emeritus at Case Western Reserve School of Law, said it's possible, but not certain, that pressure on Congress from either President Trump or others in the executive branch would lead to new, preemptive federal laws. "If the president says this is a big priority, then maybe a fair number of people in both the House and the Senate would go along with it," Entin said. "Now, whether there will be enough votes, that's a separate question," he added. "Congress does not legislate very much." "If Congress wants to move legislation against state laws that they say hurt the economy, they need 60 votes in the Senate," Entin said. "And the chances of getting 60 votes in the Senate for much of anything these days are pretty slim." The Supreme Court has largely upheld Congress' power over interstate commerce in a series of cases evaluating the Commerce Clause stretching back more than 80 years. In 1942, the Supreme Court issued a landmark decision in Wickard v. Filburn that expanded the federal government's regulatory power under the Commerce Clause. The case involved an Ohio farmer who grew more wheat than permitted under the Agricultural Adjustment Act of 1938. The court rejected the farmer's argument that the federal government could not regulate his excess wheat supply under the act because it was grown for personal, rather than commercial, use. In a unanimous 8-0 decision, the court reasoned that while a single farmer's excess crop may not substantially impact interstate commerce, the same actions, if taken in the aggregate by multiple farmers, could indeed influence the national market. Despite the Supreme Court's longstanding support for expansive application of the Commerce Clause, Entin suspects that even new federal legislation could fail to preempt certain state laws. States still retain their police powers, he said, and can exercise those powers as long as doing so doesn't interfere with interstate commerce. "It's not clear to me that Congress can use its commerce power to preempt the state's exercise of their police powers, even if state laws may, in fact, be unwise or even foolish," Entin said. The 'dormant' Commerce Clause Still another, and equally uncertain, path to challenge state laws could involve a judge-created theory known as the "Dormant Commerce Clause," the lawyers said. The concept further expands Congress' power over interstate and foreign commerce by limiting states' authority to regulate commerce even when Congress has not directly legislated on an issue. The theory is intended to prevent states from adopting discriminatory, protectionist laws that benefit local economies to the detriment of the national market. The theory was put to the test and shown to have limits in a recent case decided by the Supreme Court. In 2023, the court loosely upheld a California state law known as Proposition 12, which criminalized California sales of pork meat that came from pigs housed in pens measuring less than 24 square feet — 10 square feet larger than the industry standard. The Iowa Pork Producers Association and 23 states argued that the law discriminated against out-of-state pork producers, imposing excessive burdens on interstate commerce. However, Berman said, Dormant Commerce Clause challenges to state rules have historically been brought by private litigants, not the federal government. "It's going to be a private business sector actor saying, 'Our business is being harmed ... we shouldn't have barriers to markets along state lines." Entin agreed that it would be unusual for the federal government to sue states over their regulations. Alternatively, he said, Congress could try to persuade states to change laws through conditional federal spending. The administration may not find support from the high court for pushing Congress' authority over commerce even further, Entin added. Conservatives on the court in recent years have expressed "real skepticism" about whether courts should be in the business of enforcing the Commerce Clause, he said. Alexis Keenan is a legal reporter for Yahoo Finance. Follow Alexis on X @alexiskweed. Sign in to access your portfolio

Trump expands 50% tariff on steel and aluminum to 400 additional product types
Trump expands 50% tariff on steel and aluminum to 400 additional product types

Yahoo

time2 minutes ago

  • Yahoo

Trump expands 50% tariff on steel and aluminum to 400 additional product types

The Department of Commerce announced that President Donald Trump's 50% tariff on imported steel and aluminum products has been expanded to cover more than 400 additional categories. The expanded tariff list, published Friday by U.S. Customs and Border Protection and entered into the Federal Register on Tuesday, took effect Monday. The new duties now apply to a wide range of goods, including auto parts, electric vehicle components, railcars, marine engines, construction equipment, wind turbines, cranes, chemicals, plastics, and household items such as refrigerators, freezers, dryers, and furniture components. 'Today's action expands the reach of the steel and aluminum tariffs and shuts down avenues for circumvention — supporting the continued revitalization of the American steel and aluminum industries,' Jeffrey Kessler, Commerce Department Secretary for Industry and Security, said in a news release. The move follows petitions from U.S. steelmakers, including Cleveland-Cliffs and Nucor, urging the administration to broaden import duties to cover more derivative products. Industry experts said the expansion marks a significant shift in how steel and aluminum imports are regulated. 'Auto parts, chemicals, plastics, furniture components — basically, if it's shiny, metallic, or remotely related to steel or aluminum, it's probably on the list,' Brian Baldwin, vice president of customs at Kuehne + Nagel International AG, wrote on LinkedIn. In 2024, the U.S. imported nearly $33 billion worth of steel and aluminum, according to SteelRadar. Canada remains the largest supplier, followed by Brazil and Mexico. The Mexican Institute for Competitiveness (IMCO) estimates the tariffs will affect 4.7% of Mexican exports to the U.S. 'Aluminum and steel are vital for the manufacture of products ranging from utensils to airplanes and railroad equipment,' IMCO researcher Isaac Cruz wrote earlier this year. 'U.S. manufacturers benefit from competitive prices that would be lost if tariffs were implemented; the same is true for American consumers and families.' Mexico has requested an exemption from the new tariffs. 'We're discussing the application of tariffs on steel products because they're stretching the boundaries and adding more things, and that could hurt us,' Marcelo Ebrard, Mexico's economy secretary, said on Saturday, according to Opportimes. 'But, at the end of the day, what do we want to achieve? A position (on tariffs) for Mexico that's better than any other country.' The post Trump expands 50% tariff on steel and aluminum to 400 additional product types appeared first on FreightWaves. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Think It's Too Late to Buy Rivian? Here's the No. 1 Reason Why There's Still Time.
Think It's Too Late to Buy Rivian? Here's the No. 1 Reason Why There's Still Time.

Yahoo

time2 minutes ago

  • Yahoo

Think It's Too Late to Buy Rivian? Here's the No. 1 Reason Why There's Still Time.

Key Points Rivian's growth rates could spike next year. But the electric vehicle manufacturer still lacks one key growth driver. 10 stocks we like better than Rivian Automotive › Rivian Automotive (NASDAQ: RIVN) is about to enter one of the most exciting growth spurts in its history. It plans to launch a new discounted model in as little as six months, with two more new models to follow soon after. These launches could easily double or even triple the company's revenue over the coming years. That has investors excited and the stock price on the rise. Think it's too late to invest? Think again. There's one reason Rivian shares remain surprisingly cheap. Rivian doesn't have this exciting business segment Other electric vehicle stocks like Tesla and Lucid Group trade at 6 to 13 times trailing sales. Rivian, meanwhile, trades at just 2.6 times trailing sales. Why the big discount? Growth is a big part of the story. Lucid is expected to grow its sales by 60% this fiscal year, while Rivian's sales are expected to grow by just 6.5%. Tesla is the outlier. Analysts expect its sales to fall by around 5% this year. Why then does Tesla stock remain extremely expensive? It turns out that both Lucid and Tesla have a growth opportunity that Rivian hasn't pursued very aggressively: robotaxis. Robotaxis are expected to be a huge market. Some analysts think the global opportunity could eventually be worth up to $10 trillion. Recent robotaxi announcements from both Lucid and Tesla, therefore, have given investors plenty of optimism for long-term growth potential. Rivian has been surprisingly quiet on the robotaxi front. One of its board members even recently criticized Tesla's efforts, stressing that the service has a long way to go to be truly autonomous. A lack of robotaxi upside is likely a strong reason why Rivian shares are priced at such a relative discount to the competition. The robotaxi opportunity is still very early stages, however. Rivian's new models, meanwhile, are near-term opportunities. We should see growth rates pick up considerably next year, allowing investors to take advantage of today's discounted valuation. Rivian simply doesn't need robotaxis to grow considerably in 2025. Should you invest $1,000 in Rivian Automotive right now? Before you buy stock in Rivian Automotive, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rivian Automotive wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $654,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,076,588!* Now, it's worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Ryan Vanzo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy. Think It's Too Late to Buy Rivian? Here's the No. 1 Reason Why There's Still Time. was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store